• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbiol Resour Announc . SARS-CoV-2 Genome Sequence Obtained from Ethiopia

tetano

Editor, Senior Moderator
Microbiol Resour Announc


. 2022 Feb 3;e0118221.
doi: 10.1128/mra.01182-21. Online ahead of print.
SARS-CoV-2 Genome Sequence Obtained from Ethiopia


Molalegne Bitew[SUP] 1 [/SUP], Getnet Hailu[SUP] 2 [/SUP], Yakob Gebregziabher Tsegay[SUP] 3 [/SUP], Keyru Tuki[SUP] 1 [/SUP], Kominist Asmamaw[SUP] 1 [/SUP], Kassahun Tesfaye[SUP] 1 [/SUP], Hailu Dadi[SUP] 1 [/SUP], Emanuele Orsini[SUP] 4 [/SUP], Simeone Dal Monego[SUP] 5 [/SUP], Danilo Licastro[SUP] 5 [/SUP], Alessandro Marcello[SUP] 4 [/SUP]



Affiliations

Abstract

The coding-complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome sequences from 15 nasopharyngeal swabs collected in Addis Ababa, Ethiopia, during the period from December 2020 to March 2021 were determined using Illumina MiSeq technology. A sequence analysis identified that the B.1 SARS-CoV-2 lineage was most prevalent with the worrying emergence of B.1.1.7 in June 2021.
 
Back
Top Bottom